Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
Hangzhou Minsheng Binjiang Pharma (HMBP) is wholly-owned by Minsheng Pharma (founded in 1926). It obtained US FDA approval in 2011 & 2014 for solid dosage forms. The plant owns one blister line and one bottle line and focuses on generics for regulated markets.
Based on APIs and focused on preparations, the company produces and develops products of high-tech. It produces active pharmaceutical ingredients and four categories of drug formulations . All of the products and facilities have GMP certificates issued by SDA(State Drug Administration).
|Sales markets||Western Europe; Eastern Europe; Asia; North America; Central/South America|
|Primary business activity||Manufacturer|
|Affiliated categories:||Capsules |Contract Manufacturing |Contract Packaging More|
CPhI North America 201930 April - 2 May 2019 Chicago, USA We were at stand 838 See our Exhibitor Profile See full Exhibitor List
CPhI North America 201824-26 April, 2018 Philadelphia, USA We were at stand 742 See our Exhibitor Profile See full Exhibitor List
Our Top products
Hangzhou Minsheng Binjiang Pharm.Co.Ltd offers wide range of tablets which includes raceanisodamine tablets. Contact us for more information.More info
Hangzhou Minsheng Binjiang Pharm.Co.Ltd offers wide range of api which includes amiloride hcl. Contact us for more information.More info
Categories affiliated with Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation